Results 201 to 210 of about 19,107,871 (325)
Fenobody: A Ferritin-Displayed Nanobody with High Apparent Affinity and Half-Life Extension.
Ke-Long Fan +8 more
semanticscholar +1 more source
ABSTRACT Objective To clarify the clinical relevance of dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) abnormalities in amyotrophic lateral sclerosis (ALS), with a prespecified focus on sex‐stratified associations with disease progression and short‐term prognosis.
Tomoya Kawazoe +7 more
wiley +1 more source
Quantifying learning curves in ultrasound training: a real-time consultation analysis using a novel half-life metric. [PDF]
Wang Y, Wang YH, Yang X, Cai S, Li JC.
europepmc +1 more source
ABSTRACT Objectives We aimed to determine the frequency of subclinical optic nerve (ON) lesions using MRI, optical coherence tomography (OCT), and visual evoked potentials (VEP) in radiologically isolated syndrome (RIS), and to assess their diagnostic and prognostic significance.
Christine Lebrun‐Frenay +13 more
wiley +1 more source
Multi-modal feature learning to prioritize ADCs with favorable half-life in mice. [PDF]
Zhu XW +6 more
europepmc +1 more source
Extended Half-Life Factor VIII and Factor IX Preparations
L. Graf
semanticscholar +1 more source
Digital Cognitive Phenotyping for Differential Diagnosis and Monitoring in Neurological Conditions
ABSTRACT Objective To assess the utility, accessibility, and equivalence to supervised scales of online cognitive assessment in older individuals with cognitive impairment. Methods Patients with Alzheimer's disease (AD, n = 31), idiopathic normal pressure hydrocephalus (iNPH, n = 26), and traumatic brain injury (TBI, n = 23) completed online cognitive ...
Martina Del Giovane +10 more
wiley +1 more source
Computational modeling of intravitreal ranibizumab kinetics: Predicting macular drug concentration and half-life. [PDF]
Chowdhury JM.
europepmc +1 more source
Strategy for Extending Half-life in Drug Design and Its Significance.
H. Gunaydin +6 more
semanticscholar +1 more source
ABSTRACT Objective Building on our prior Behavioral Risk Factor Surveillance System analysis identifying adults aged 18–39 as the primary driver of the national increase in self‐reported cognitive disability, we examined factors associated with this rise using 2013–2024 U.S. BRFSS data. Methods We analyzed U.S.
Adam de Havenon +9 more
wiley +1 more source

